Patents by Inventor Matthew COONS

Matthew COONS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12673094
    Abstract: The present invention in particular relates to a method of producing an immunogenic composition exhibiting reduced virucidal activity, as well as to the immunogenic composition and uses thereof, wherein the method in particular comprises the steps of: (a) providing a mixture with a first liquid and a recombinant protein, (b) concentrating the recombinant protein in the mixture by removing a portion of the first liquid from the mixture, and (c) processing the solution resulting from step (b) by continuous diafiltration.
    Type: Grant
    Filed: March 25, 2024
    Date of Patent: July 7, 2026
    Assignee: Boehringer Ingelheim Animal Health USA Inc.
    Inventors: Leigh Wilmes, Matthew Coons, Amanda Brown, Michael Johannes Gassel, Francois-Xavier Orveillon, Katharina Hedwig Toepfer, Elida Bautista, Kathy Schlesinger
  • Publication number: 20240350612
    Abstract: The present invention in particular relates to a method of producing an immunogenic composition exhibiting reduced virucidal activity, as well as to the immunogenic composition and uses thereof, wherein the method in particular comprises the steps of: (a) providing a mixture with a first liquid and a recombinant protein, (b) concentrating the recombinant protein in the mixture by removing a portion of the first liquid from the mixture, and (c) processing the solution resulting from step (b) by continuous diafiltration.
    Type: Application
    Filed: March 25, 2024
    Publication date: October 24, 2024
    Applicant: Boehringer Ingelheim Animal Health USA Inc.
    Inventors: Leigh WILMES, Matthew COONS, Amanda BROWN, Michael Johannes GASSEL, Francois-Xavier ORVEILLON, Katharina Hedwig TOEPFER, Elida BAUTISTA, Kathy SCHLESINGER
  • Patent number: 11957746
    Abstract: The present invention in particular relates to a method of producing an immunogenic composition exhibiting reduced virucidal activity, as well as to the immunogenic composition and uses thereof, wherein the method in particular comprises the steps of: (a) providing a mixture with a first liquid and a recombinant protein, (b) concentrating the recombinant protein in the mixture by removing a portion of the first liquid from the mixture, and (c) processing the solution resulting from step (b) by continuous diafiltration.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: April 16, 2024
    Inventors: Leigh Wilmes, Matthew Coons, Amanda Brown, Michael Johannes Gassel, Francois-Xavier Orveillon, Katharina Hedwig Toepfer, Elida Bautista, Kathy Schlesinger
  • Publication number: 20220409715
    Abstract: The present invention in particular relates to a method of producing an immunogenic composition exhibiting reduced virucidal activity, as well as to the immunogenic composition and uses thereof, wherein the method in particular comprises the steps of: (a) providing a mixture with a first liquid and a recombinant protein, (b) concentrating the recombinant protein in the mixture by removing a portion of the first liquid from the mixture, and (c) processing the solution resulting from step (b) by continuous diafiltration.
    Type: Application
    Filed: March 25, 2019
    Publication date: December 29, 2022
    Inventors: Leigh WILMES, Matthew COONS, Amanda BROWN, Michael Johannes GASSEL, Francois-Xavier ORVEILLON, Katharina Hedwig TOEPFER, Elida BAUTISTA, Kathy SCHLESINGER